Saturday, May 31, 2025

Latest

Tilray Hires New Chief Financial Officer, Chief Operating Officer

Tilray Inc (NASDAQ: TLRY) has bolstered its executive team this morning, with the appointment of both a new chief operating officer, as well as a new chief financial officer. Both executives come with a long resume of high profile firms in which they have served senior roles.

Michael Kruteck will be taking over as CFO of the firm, which will be effective immediately after Tilray completes and files its Annual Report on Form 10-K for the fiscal year end. He will be replacing Mark Castaneda, who will be staying with the company in the role of Strategic Business Development following the customary transition of the CFO role.

Kruteck comes most recently from that of Pharmica Integrative Pharmacy where he served as CFO. Prior to this, he served in numerous senior financial roles at Molson Coors. Kruteck has specific experience in financial and operation transformation, supply chains and corporate finance.

Taking the role of COO will be that of Jon Levin. Levin joins the company from Revlon, where he served as General Manager of US Mass Markets for consumer products sold through retailers. He has over twenty five years experience in the fields of health and beauty and consumer packaged goods. Previously, he served at Ferrara Candy Company, Nautilus and Wrigley among others.

Tilray last traded at $17.37 on the Nasdaq.


Information for this briefing was found via Sedar and Tilray. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Alamos Gold Q1 Earnings: The Inside Scoop

Cerrado Gold Q4 Earnings: The Turnaround is Working

B2GOLD Q1 Earnings: Revenue Up, Production & Cash Flow Decline

Recommended

Canadian Copper: The $172M Combined Strategy PEA

ESGold Begins Concentration Tests Ahead Of First Production

Related News

Tilray Sees Revenue Decline To $144.1 Million In Q2 2023

Tilray Brands (TSX: TLRY) appears to be struggling when it comes to topline revenue. The...

Monday, January 9, 2023, 08:29:13 AM

Tilray: Haywood Reiterates Hold Rating, $16.50 Price Target

With the Aphria, Tilray (NASDAQ: TLRY) merger finalized and Aphria shares consolidated earlier this month,...

Wednesday, May 19, 2021, 03:38:00 PM

Tilray To Shut Down Natura Naturals Facility

Tilray Inc (NASDAQ: TLRY) will be closing a facility it acquired just last year as...

Tuesday, May 26, 2020, 04:45:13 PM

Tilray: Haywood Slashes Price Target From $7.25 To $4.00

Tilray Brands (TSX: TLRY) is expected to report its fiscal fourth-quarter results on July 26th....

Wednesday, July 13, 2022, 02:54:00 PM

More Than 80% of Canada’s Cannabis CEOs at the Time of Adult-Use Legalization Have Left

Three years into adult-use legalization – fewer than 1 in 5 CEOs who were there...

Sunday, October 24, 2021, 09:00:00 AM